The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen arc increased by formulation with CpG oligodeoxynucleotides

被引:106
作者
Ioannou, XP
Griebel, P
Hecker, R
Babiuk, LA
Littel-van den Hurk, SV
机构
[1] Vet Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
[2] Qiagen GmbH, D-40724 Hilden, Germany
关键词
D O I
10.1128/JVI.76.18.9002-9010.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The immunogenicity and protective efficacy of a bovine herpesvirus 1 (BHV-1) subunit vaccine formulated with Emulsigen (Em) and a synthetic oligodeoxynucleotide containing unmethylated CpG dinucleotides (CpG ODN) was determined in cattle. A truncated, secreted version of BHV-1 glycoprotein D (tgD) formulated with Em and CpG ODN at concentrations of 25, 2.5, or 0.25 mg/dose produced a more balanced immune response, higher levels of virus neutralizing antibodies, and greater protection after BHV-1 challenge compared to tgD adjuvanted with either Em or CpG ODN alone. In contrast, tgD formulated with Em and either 25 mg of a non-CpG ODN or another immunostimulatory compound, dimethyl dioctadecyl ammonium bromide, induced similar immunity and protection compared to tgD formulated with Em alone, a finding which confirms the immunostimulatory effect of ODN to be CpG motif mediated. Our results demonstrate the ability of CpG ODN to induce a strong and balanced immune response in a target species.
引用
收藏
页码:9002 / 9010
页数:9
相关论文
共 56 条
[1]   Immunology of bovine herpesvirus 1 infection [J].
Babiuk, LA ;
LittelvandenHurk, SV ;
Tikoo, SK .
VETERINARY MICROBIOLOGY, 1996, 53 (1-2) :31-42
[2]   DEFENSE-MECHANISMS AGAINST BOVINE HERPESVIRUS - RELATIONSHIP OF VIRUS-HOST CELL EVENTS TO SUSCEPTIBILITY TO ANTIBODY-COMPLEMENT CELL LYSIS [J].
BABIUK, LA ;
WARDLEY, RC ;
ROUSE, BT .
INFECTION AND IMMUNITY, 1975, 12 (05) :958-963
[3]   Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: Effect of antigen form on the induction of cellular and humoral immune responses [J].
BacaEstrada, ME ;
Snider, M ;
Tikoo, SK ;
Harland, R ;
Babiuk, LA ;
LittelVandenHurk, SV .
VIRAL IMMUNOLOGY, 1996, 9 (01) :11-22
[4]  
Bomford R, 1998, DEV BIOL STAND, V92, P13
[5]   THE SKIN IMMUNE-SYSTEM - PROGRESS IN CUTANEOUS BIOLOGY [J].
BOS, JD ;
KAPSENBERG, ML .
IMMUNOLOGY TODAY, 1993, 14 (02) :75-78
[6]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631
[7]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[8]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[9]  
Davis HL, 1998, J IMMUNOL, V160, P870
[10]   Plasmid vectors as anti-viral vaccines [J].
Ertl, HCJ ;
Verma, P ;
He, Z ;
Xiang, ZQ .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :77-87